166 related articles for article (PubMed ID: 34520027)
1. Interest in long-acting injectable buprenorphine among syringe services program participants.
Epstein H; Perez-Correa A; Beltre J; Fitzsimmons C; Marcus P; Ramirez F; Stern LS; Norton BL; Fox AD; Jakubowski A
J Opioid Manag; 2021; 17(7):59-67. PubMed ID: 34520027
[TBL] [Abstract][Full Text] [Related]
2. High Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among Urban Syringe Service Program Participants.
Fox AD; Riback L; Perez-Correa A; Ohlendorf E; Ghiroli M; Behrends CN; López-Castro T
Subst Use Addctn J; 2024 Jan; 45(1):44-53. PubMed ID: 38258851
[TBL] [Abstract][Full Text] [Related]
3. Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.
Jakubowski A; Rath C; Harocopos A; Wright M; Welch A; Kattan J; Navos Behrends C; Lopez-Castro T; Fox AD
Harm Reduct J; 2022 Jul; 19(1):75. PubMed ID: 35818071
[TBL] [Abstract][Full Text] [Related]
4. Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.
Shah PA; Sohler NL; López C; Fox AD; Cunningham CO
J Opioid Manag; 2013; 9(6):407-13. PubMed ID: 24481929
[TBL] [Abstract][Full Text] [Related]
5. Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.
Jakubowski A; Norton BL; Hayes BT; Gibson BE; Fitzsimmons C; Stern LS; Ramirez F; Guzman M; Spratt S; Marcus P; Fox AD
J Addict Med; 2022 Jul-Aug 01; 16(4):447-453. PubMed ID: 34775441
[TBL] [Abstract][Full Text] [Related]
6. Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.
Perez-Correa A; Abbas B; Riback L; Ghiroli M; Norton B; Murphy S; Jakubowski A; Hayes BT; Cunningham CO; Fox AD
Contemp Clin Trials; 2022 Mar; 114():106674. PubMed ID: 34990854
[TBL] [Abstract][Full Text] [Related]
7. Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.
Jakubowski A; Fowler S; Fox AD
Addict Sci Clin Pract; 2023 Jun; 18(1):40. PubMed ID: 37301953
[TBL] [Abstract][Full Text] [Related]
8. "We'll be able to take care of ourselves" - A qualitative study of client attitudes toward implementing buprenorphine treatment at syringe services programs.
Frost T; Deutsch S; Brown S; Lemien E; Cunningham CO; Fox AD
Subst Abus; 2021; 42(4):983-989. PubMed ID: 33759722
[No Abstract] [Full Text] [Related]
9. Exploring the effectiveness of a regional nurse practitioner led, long-acting injectable buprenorphine-based model of care for opioid use disorder.
Strike T; D'Angelo-Kemp D; Searby A
Int J Ment Health Nurs; 2023 Aug; 32(4):1129-1137. PubMed ID: 37070663
[TBL] [Abstract][Full Text] [Related]
10. Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study.
Saunders EC; Budney AJ; Cavazos-Rehg P; Scherer E; Bell K; John D; Marsch LA
J Subst Use Addict Treat; 2024 Aug; 163():209383. PubMed ID: 38670531
[TBL] [Abstract][Full Text] [Related]
11. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.
Saunders EC; Moore SK; Walsh O; Metcalf SA; Budney AJ; Scherer E; Marsch LA
J Subst Abuse Treat; 2020 Apr; 111():54-66. PubMed ID: 32076361
[TBL] [Abstract][Full Text] [Related]
12. Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs.
Lambdin BH; Kan D; Kral AH
Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):51. PubMed ID: 35841036
[TBL] [Abstract][Full Text] [Related]
13. 'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.
Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A
Int J Drug Policy; 2023 May; 115():104002. PubMed ID: 37003194
[TBL] [Abstract][Full Text] [Related]
14. Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
Rolland B; Trojak B; Nourredine M; Bachellier J; Chappuy M; Bendimerad P; Kosim M; Hjelmström P; Meroueh F; Nubukpo P; Brousse G
Drug Alcohol Depend; 2021 Mar; 220():108492. PubMed ID: 33482572
[TBL] [Abstract][Full Text] [Related]
15. How do patients feel during the first 72 h after initiating long-acting injectable buprenorphine? An embodied qualitative analysis.
Neale J; Parkin S; Strang J
Addiction; 2023 Jul; 118(7):1329-1339. PubMed ID: 36808168
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
[TBL] [Abstract][Full Text] [Related]
17. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
18. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
[TBL] [Abstract][Full Text] [Related]
19. [New slow-release buprenorphine formulations for optimization of opioid substitution].
Soyka M; Pogarell O
Nervenarzt; 2019 Sep; 90(9):932-937. PubMed ID: 31399813
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
Dunn KE; Tompkins DA; Bigelow GE; Strain EC
JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
